Water-soluble rice bran enzymatic extract attenuates dyslipidemia, hypertension and insulin resistance in obese Zucker rats

European Journal of Nutrition

Volumn 52, Issue 2, 2013, Pages 789-797

  Justo, Maria L ^a   Rodriguez–Rodriguez, Rosalia ^a   Claro, Carmen M ^a   Alvarez De Sotomayor, Maria ^a   Parrado, Juan ^a   Herrera, Maria D ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Dyslipidemia; Hypertension; Insulin resistance; Metabolic syndrome; Obese Zucker rats; Rice bran

Indexed keywords

ADIPONECTIN; CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; NATURAL PRODUCT; NITRATE; RICE BRAN ENZYMATIC EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MECHANISM; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; RAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ZUCKER RAT;

ANIMALIA; RATTUS;

EID: 84879554335     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-012-0385-6     Document Type: Article

References (43)

1. Jariwalla RJ (2001) Rice-bran products: phytonutrients with potential applications in preventive and clinical medicine. Drugs Exp Clin Res 27:17-26
2. Ha TY, Han S, Kim SR, Kim IH, Lee HY, Kim HK (2005) Bioactive components in rice bran oil improve lipid profiles in rats fed a high-cholesterol diet. Nutr Res 25:597-606
3. Cicero AF, Gaddi A (2001) Rice bran oil and gamma-oryzanol in the treatment of hyperlipoproteinaemias and other conditions. Phytother Res 15:277-289
4. Fabian C, Ju YH (2011) A review on rice bran protein: its properties and extraction methods. Crit Rev Food Sci Nutr 51:816-827
5. Sunitha T, Manorama R, Rukmini C (1997) Lipid profile of rats fed blends of rice bran oil in combination with sunflower and safflower oil. Plant Foods Hum Nutr 51:219-230
6. Berger A, Rein D, Schäfer A, Monnard I, Gremaud G, Lambelet P, Bertoli C (2005) Similar cholesterol-lowering properties of rice bran oil, with varied gamma-oryzanol, in mildly hypercholesterolemic men. Eur J Nutr 44:163-173
7. Ausman LM, Rong N, Nicolosi RJ (2005) Hypocholesterolemic effect of physically refined rice bran oil: studies of cholesterol metabolism and early atherosclerosis in hypercholesterolemic hamsters. J Nutr Biochem 16:521-529
8. Wilson TA, Nicolosi RJ, Woolfrey B, Kritchevsky D (2007) Rice bran oil and oryzanol reduce plasma lipid and lipoprotein cholesterol concentrations and aortic cholesterol ester accumulation to a greater extent than ferulic acid in hypercholesterolemic hamsters. J Nutr Biochem 18:105-112
9. Chopra R, Sambaiah K (2009) Effects of rice bran oil enriched with n-3 PUFA on liver and serum lipids in rats. Lipids 44:37-46
10. Qureshi AA, Sami SA, Khan FA (2002) Effects of stabilized rice bran, its soluble and fiber fractions on blood glucose levels and serum lipid parameters in humans with diabetes mellitus types I and II. J Nutr Biochem 13:175-187
11. Chen CW, Cheng HH (2006) A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Nutr 136:1472-1476
12. Chou TW, Ma CY, Cheng HH, Chen YY, Lai MH (2009) A rice bran oil diet improves lipid abnormalities and suppress hyperinsulinemic responses in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Clin Biochem Nutr 45:29-36
13. Siddiqui S, Rashid Khan M, Siddiqui WA (2010) Comparative hypoglycemic and nephroprotective effects of tocotrienol rich fraction (TRF) from palm oil and rice bran oil against hyperglycemia induced nephropathy in type 1 diabetic rats. Chem Biol Interact 188:651-658
14. Parrado J, Miramontes E, Jover M, Márquez JC, Angeles Mejias M, Collantes De Teran L, Absi E, Bautista J (2003) Prevention of brain protein and lipid oxidation elicited by a water-soluble oryzanol enzymatic extract derived from rice bran. Eur J Nutr 42:307-314
15. Parrado J, Miramontes E, Jover M, Gutierrez JF, Collantes de Terán L, Bautista J (2006) Preparation of a rice bran enzymatic extract with potential use as functional food. Food Chem 98:742-748
16. Revilla E, Santa Maria C, Miramontes E, Bautista J, García- Martínez A, Cremades O, Cert R, Parrado J (2009) Nutraceutical composition, antioxidant activity and hypocholesterolemic effect of a water-soluble enzymatic extract from rice bran. Food Res Int 42:387-393
17. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415-1428
18. Bruce KD, Hanson MA (2010) The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr 140:648-652
19. Davi G, Santilli F, Patrono C (2010) Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc Ther 28:216-226
20. Abete I, Goyenechea E, Zulet MA, Martínez JA (2011) Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis S2:B1-15
21. Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HH, Martínez JA (2010) Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition 26:534-541
22. Mingorance C, Álvarez de Sotomayor M, Jiménez-Palacios FJ, Callejón M, Casto C, Marhuenda E, Herrera MD (2009) Effects of chronic treatment with the CB1 antagonist, rimonabant on the blood pressure, and vascular reactivity of obese Zucker rats. Obesity 17:1340-1347
23. Rodriguez-Rodriguez R, Herrera MD, de Sotomayor MA, Ruiz-Gutierrez V (2007) Pomace olive oil improves endothelial function in spontaneously hypertensive rats by increasing endothelial nitric oxide synthase expression. Am J Hypertens 20:728-734
24. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
25. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645
26. Juliano BO (1985) Rice bran. In: Rice chemistry and technology. American Association of Cereal Chemists, St. Paul, pp 647'680
27. Luh BS (1991) Rice production. Van Nostrand Reinhold, New York
28. Raz I, Eldor R, Cernea S, Shafrir E (2005) Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab Res Rev 21:3-14
29. Sugano M, Tsuji E (1997) Rice bran oil and cholesterol metabolism. J Nutr 127:521S-524S
30. Sasaki J, Takada Y, Handa K, Kusuda M, Tanabe Y, Matsunaga A, Arakawa K (1990) Effects of gamma-oryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizers. Clin Ther 12:263-268
31. Kiribuchi M, Miura K, Tokuda S, Kaneda T (1983) Hypocholesterolemic effect of triterpene alcohols with soysterol on plasma cholesterol in rats. J Nutr Sci Vitaminol (Tokyo) 29:35-43
32. Ni W, Tsuda Y, Takashima S, Sato H, Sato M, Imaizumi K (2003) Anti-atherogenic effect of soya and rice-protein isolate, compared with casein, in apolipoprotein E-deficient mice. Br J Nutr 90:13-20
33. Minhajuddin M, Beg ZH, Iqbal J (2005) Hypolipidemic and antioxidant properties of tocotrienol rich fraction isolated from rice bran oil in experimentally induced hyperlipidemic rats. Food Chem Toxicol 43:747-753
34. Qureshi AA, Sami SA, Salser WA, Khan FA (2002) Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 161:199-207
35. Haslam DW, James WP (2005) Obesity. Lancet 366:1197-1209
36. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784-1792
37. Frisbee JC, Delp MD (2006) Vascular function in the metabolic syndrome and the effects on skeletal muscle perfusion: lessons from the obese Zucker rat. Essays Biochem 42:145-161
38. Nagasaka R, Yamsaki T, Uchida A, Ohara K, Ushio H (2011) γ-Oryzanol recovers mouse hypoadiponectinemia induced by animal fat ingestion. Phytomedicine 18:669-671
39. Suzuki A, Kagawa D, Fujii A, Ochiai R, Tokimitsu I, Saito I (2002) Short- and long-term effects of ferulic acid on blood pressure in spontaneously hypertensive rats. Am J Hypertens 15:351-357
40. Ardiansyah SH, Koseki T, Hashizume K, Komai M (2007) The Driselase-treated fraction of rice bran is a more effective dietary factor to improve hypertension, glucose and lipid metabolism in stroke-prone spontaneously hypertensive rats compared to ferulic acid. Br J Nutr 97:67-76
41. Ardiansyah Ohsaki Y, Shirakawa H, Koseki T, Komai M (2008) Novel effects of a single administration of ferulic acid on the regulation of blood pressure and the hepatic lipid metabolic profile in stroke-prone spontaneously hypertensive rats. J Agric Food Chem 56:2825-2830
42. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K (2003) Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14:561-566
43. Islam MS, Yoshida H, Matsuki N, Ono K, Nagasaka R, Ushio H, Guo Y, Hiramatsu T, Hosoya T, Murata T, Hori M, Ozaki H (2009) Antioxidant, free radical-scavenging, and NF-kappaB-inhibitory activities of phytosteryl ferulates: structure-activity studies. J Pharmacol Sci 111:328-337